With this issue of Diabetes Care, we are pleased to add another feature we believe will enhance the experience of our readership. By linking some of the articles we publish to relevant recordings of scientific presentations, we hope to provide you with greater insight into topics of importance that should be of value in delivering care to people with diabetes.
The annual American Diabetes Association Scientific Sessions provide attendees with an opportunity to hear from experts on a variety of topics. Many of the presentations given ultimately become submissions to Diabetes Care and, after full peer review, are accepted for publication in the journal. In instances where this research is part of organized symposia that are recorded at the Scientific Sessions, we are now able to offer our readers the opportunity to watch, free of charge, the taped recordings from these symposia and hear the speakers’ interpretation of their data and their discussions of implications for the field.
To identify the articles that have a linked presentation and are available for your viewing, the monthly table of contents now includes a video icon. These recordings will be accessible to the readership well beyond the time they can be viewed by meeting attendees. This opportunity commences in this issue with the review “The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice,” which is based on the Diabetes Care symposium, and two articles that present glycemia-related data from the Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) study that were discussed in the symposium SELECT Trial—New Looks at Glycemia, Inflammation, and Heart Failure. We thank the American Diabetes Association for allowing us to offer you this additional opportunity associated with your journal subscription.
We hope that this new feature, along with our podcast Diabetes Care “On Air,” which highlights selected articles from each issue, will continue to enhance your learning experience.
Article Information
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
